Anticorps Recombinant de lapin anti-Tissue Factor/CD142
Tissue Factor/CD142 Recombinant Antibody for FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
FC
Conjugaison
Non conjugué
CloneNo.
240784E2
N° de cat : 98104-1-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en cytométrie | CMSP humaines traitées au LPS, |
Dilution recommandée
| Application | Dilution |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98104-1-RR cible Tissue Factor/CD142 dans les applications de FC et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | Tissue Factor/CD142 Protéine recombinante Eg1052 |
| Nom complet | coagulation factor III (thromboplastin, tissue factor) |
| Masse moléculaire calculée | 33 kDa |
| Numéro d’acquisition GenBank | NM_001993.5 |
| Symbole du gène | F3 |
| Identification du gène (NCBI) | 2152 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
Normal blood coagulation is a complex process, involving a cascade of activation of different plasma proteins, ultimately resulting in the formation of a clot, called fibrin. Tissue Factor (TF), also named CD142, coagulation factor III or F3, is the primary initiator of the blood coagulation cascade and plays an essential role in hemostasis (PMID: 26877187; PMID: 33796108).
Protocole
| Product Specific Protocols | |
|---|---|
| FC protocol for Tissue Factor/CD142 antibody 98104-1-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |


